Abstract:On-the-fly biofabrication of reproducible 3D tumor models at a pre-clinical level is highly desirable to level-up their applicability and predictive potential. Incorporating ECM biomolecular cues and its complex 3D bioarchitecture in the design stages of such in vitro platforms is essential to better recapitulate the native tumor microenvironment. To materialize these needs, herein we describe an innovative flow-on-repellent (FLORE) 3D extrusion bioprinting technique that leverages expedited and automatized bioink deposition onto a customized superhydrophobic printing bed. We demonstrate that this approach enables the rapid generation of quasi-spherical breast cancer-stroma hybrid models in a mode governed by surface wettability rather than bioink rheological features. For this purpose, an ECM-mimetic bioink comprising breast tissue-specific decellularized matrix in the form of microfiber bundles (dECM-μF) and photocrosslinkable hyaluronan (HAMA), was formulated to generate triple negative breast tumor-stroma models. Leveraging on the FLORE bioprinting approach, a rapid, automated, and reproducible fabrication of physiomimetic breast cancer hydrogel beads was successfully demonstrated. Hydrogel beads size with and without dECM-μF was easily tailored by modelling droplet deposition time on the superhydrophobic bed. Interestingly, in heterotypic breast cancer-stroma beads a self-arrangement of different cellular populations was observed, independent of dECM-μF inclusion, with CAFs clustering overtime within the fabricated models. Drug screening assays showed that the inclusion of CAFs and dECM-μF also impacted the overall response of these living constructs when incubated with gemcitabine chemotherapeutics, with dECM-μF integration promoting a trend for higher resistance in ECM-enriched models. Overall, we developed a rapid fabrication approach leveraging on extrusion bioprinting and superhydrophobic surfaces to process photocrosslinkable dECM bioinks and to generate increasingly physiomimetic tumor-stroma-matrix platforms for drug screening.

Deployable extrusion bioprinting of compartmental tumoroids with cancer associated fibroblasts for immune cell interactions

Hybrid 3D microfluidic bioprinting for the engineering of cancer models and tissue substitutes

3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation

The acoustic droplet printing of functional tumor microenvironments

A high-throughput 3D bioprinted cancer cell migration and invasion model with versatile and broad biological applicability

Inkjet-printed morphogenesis of tumor-stroma interface using bi-cellular bioinks of collagen-poly(N-isopropyl acrylamide-co-methyl methacrylate) mixture

3D Bioprinting as a Powerful Technique for Recreating the Tumor Microenvironment

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

3D Bioprinting of Multi-Cellular Tumor Microenvironment for Prostate Cancer Metastasis.

Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low Concentration Collagen Based Bioinks

Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications

Enhancing cell survival in 3D printing of organoids using innovative bioinks loaded with pre-cellularized porous microscaffolds

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

Bioprinting native-like 3D micro breast cancer tissues utilizing existing cancer cell lines

Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance

Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling

3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

A 3D bioprinted tumor model fabricated with gelatin/sodium alginate/decellularized extracellular matrix bioink

Flow-on-repellent biofabrication of fibrous decellularized breast tumor-stroma models

Embedded Bioprinting of Tumor-Scale Pancreatic Cancer-Stroma 3D Models for Preclinical Drug Screening

A Digital Manufactured Microfluidic Platform for Flexible Construction of 3D Co-Culture Tumor Model with Spatiotemporal Resolution